Capital Performance Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$267K	Buy	601 +59	+11%	+$26.3K	0.05%	178
2025 Q1	$263K	Buy	+542	New	+$263K	0.06%	181
2024 Q4	–	Sell	-83	Closed	-$38.5K	–	2632
2024 Q3	$38.5K	Buy	+83	New	+$38.5K	0.01%	420